Whether or not Congress extends the Affordable Care Act’s enhanced premium tax credits, health care giants are poised to extract new profits from patient pain.
Local governments have a lot of freedom on how to spend the funds, but there’s also confusion and a feeling of moral responsibility to spend wisely after so many lives have been lost.
The pharmaceutical industry spent decades manipulating the country’s top drug regulator into rubber-stamping its products. The Trump administration is making matters worse.
The current US health care system burdens doctors with heavy patient loads, more administrative work and additional off-hour demands. Doctor-patient interactions suffer as a result.